SuperworthStructure Therapeutics shares outstanding GPCR
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 218M
- On a year earlier
- +26.2%
- more shares
Structure Therapeutics had 218M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 26.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 190M | +11% |
| FY2024 | 171.8M | +24% |
| FY2023 | 138.6M | +1280% |
| FY2022 | 10M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 218M | +26% | |
| Q1 FY26 | 217.3M | +26% | |
| Q4 FY25 | 190M | +11% | |
| Q3 FY25 | 175.5M | +2% | |
| Q2 FY25 | 172.6M | +16% | |
| Q1 FY25 | 172.1M | +23% | |
| Q4 FY24 | 171.8M | +24% | |
| Q3 FY24 | 171.6M | +49% | |
| Q2 FY24 | 148.2M | +29% | |
| Q1 FY24 | 139.7M | +95% | |
| Q4 FY23 | 138.6M | +1280% | |
| Q3 FY23 | 114.9M | +1075% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Structure Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.